Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study
-
期刊论文
-
发表日期：
2026年5月16日
- Ashish Sharma,
- Ahmed Abdelshafy Tabl,
- Heba T. Rihani,
- Marwa Abdelshafy Tabl,
- Ahmed A. Shebl,
- Walid Samir Abousaif,
- Mutasem Elfalah,
- Moayad Shaf”ei,
- Tabarak AlSaadi,
- Arshad M. Khanani,
- David Eichenbaum,
- Carl Regillo,
- David Boyer,
- Baruch D. Kuppermann,
- Anat Loewenstein,
- Francesco Bandello,
- Giuseppe Querques,
- Tomoko Ueda-Consolvo,
- Masaaki Ishida,
- Tomoko Nakamura,
- Atsushi Hayashi,
- Kotaro Tsuboi,
- Nilesh Kumar,
- Nikulaa Parachuri,
- Jay Sheth,
- Chitaranjan Mishra,
- Debdulal Chakraborty,
- Alay Banker,
- Kourous A. Rezaei,
- Peter K. Kaiser,
- Frank G. Holz,
- Sobha Sivaprasad,
- Şengül Özdek,
- Kodjikian Laurent,
- Alper Bilgic,
- Paolo Lanzetta,
- Valentina Sarao,
- Caroline Baumal,
- Nancy Holekemp,
- Taiji Sakamoto,
- Adnan Tufail,
- Nicolas Yannuzzi,
- Giulia Corradetti,
- Aleksandra Rachitskaya,
- Tunde Peto,
- Maximilian WM Wintergerst,
- Barbara Parolini,
- Quan Dong Nguyen,
- V. D. Diana,
- Pearse A. Keane,
- Tarek Hassan,
- Dilraj S. Grewal,
- Francesc March,
- Martin S. Spitzer,
- Khalil G. Falavarjani,
- Martin S. Zinkernagel,
- Christopher Seungkyu Lee,
- Judy E. Kim,
- Se Joon Woo,
- Luke Nicholson,
- Clara Vazquez-Alfageme,
- Taku Wakabayashi
本文未提供摘要，请点击“查看全文”查看完整内容。